Physician

Ravinder Gogia, MD

According to 2025 Medicare claims, Ravinder Gogia, MD (NPI: 1083872618) practices dermatology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94903-4184.

Gogia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 864 traditional Medicare patients, billed 4,953 HCPCS/CPT codes, and received $631,222 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 626 prescription claims across 336 beneficiaries totaling $69,191 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 7 records totaling $203. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,897 and ending at $69,191. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$352K$705K2015 Medicare payment: $421,431 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $504,928 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $483,729 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $514,520 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $533,873 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $529,940 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $588,937 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $588,290 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $704,960 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $631,222 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155052,411$421,431
20166553,676$504,928
20176994,638$483,729
20187565,379$514,520
20197875,373$533,873
20206704,792$529,940
20217535,351$588,937
20227675,305$588,290
20238695,459$704,960
20248644,953$631,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$69K2015 Drug cost: $12,897 (USD; Tot_Drug_Cst)2016 Drug cost: $33,547 (USD; Tot_Drug_Cst)2017 Drug cost: $15,028 (USD; Tot_Drug_Cst)2018 Drug cost: $26,700 (USD; Tot_Drug_Cst)2019 Drug cost: $44,545 (USD; Tot_Drug_Cst)2020 Drug cost: $21,296 (USD; Tot_Drug_Cst)2021 Drug cost: $16,669 (USD; Tot_Drug_Cst)2022 Drug cost: $10,617 (USD; Tot_Drug_Cst)2023 Drug cost: $31,264 (USD; Tot_Drug_Cst)2024 Drug cost: $69,191 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015116201$12,897
2016112195$33,547
2017168273$15,028
2018229406$26,700
2019251494$44,545
2020266508$21,296
2021294561$16,669
2022250447$10,617
2023304533$31,264
2024336626$69,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks325384$549
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks181266$400
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more482611$76
17000Destruction of precancer skin growth, 1 growth350452$43
17003Destruction of precancer skin growth, 2-14 growths2851,862$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab15420$57,371
Clobetasol PropionateClobetasol Propionate351,008$1,457
MupirocinMupirocin1532,615$1,169
FluorouracilFluorouracil18522$1,094
KetoconazoleKetoconazole662,022$1,045

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$203Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ravinder Gogia, MD?

Tedicare shows public-source Medicare data for Ravinder Gogia, MD (NPI 1083872618), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ravinder Gogia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ravinder Gogia, MD?

Ravinder Gogia, MD is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Ravinder Gogia, MD have Open Payments data?

Ravinder Gogia, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.